Clinical Trials and Research
Login or register to access the content restricted to healthcare professionals only
ADVANCED CLINICAL
|
| clinical trial | Exact | Background | Current status | Comment |
| Phase I PK study | Bod ECS315 | Pharmacokinetics safety and torebility of CBD extract |
INITIATED IN PROGRESS COMPLETED |
Differentiated by Our R & D. this work optimized the design of our schedule 3 clinical trial |
| Toxicology | Bod ECS315 | Safety evaluation of ECS315 For Novel Food registration |
INITIATED IN PROGRESS COMPLETED |
We are 1 of only 6company globally to have secured a validated Novel Food Application. This is manditory for CBD to sold in the UK and EU |
| BODOLOS Observational Study | Bod ECS315 & Bod ECS100 | Real world Evidence on doctors CBD prescribing habits |
INITIATED IN PROGRESS COMPLETED |
Provided important insight into dosing decisions and design of our schedules 3 clinical trial |
| CBG pilot study | Bod ECS317 | Evaluation of the efficiency of a novel CBG compound |
INITIATED IN PROGRESS COMPLETED |
Investigate the effect of CBG on symptoms associated with fibromyalgia , inflammtory bowel disease and anxiety |
| Poject chang’e | Bod ECS317 & Bod ECS100 |
Evaluating the combination of different cannabinoids and probiotics trageting stress, anxiety and inflammtion in animals |
INITIATED IN PROGRESS |
data will support furture product launches using combination of CBG and CBD |
| phase1 PK study | BOD Bio Absorb | Pharmacokinetics, safety and tolerability of novel CBD compound |
INITIATED IN PROGRESS |
data will support FDA registration and others commercial opportunities |
| Phase II insomnia study | Bod Bio Absorb | using a novel CBD to treat insomania |
INITIATED IN PROGRESS
|
clinical trial will allow Bod to secure a registration from TGA. this will allow the product to be sold in Australian Pharmacy’s over the counter. |
| Long Covid Study | Bod ECS315 |
Evaluating the efficacy of CBD for symptoms associated with Long covid |
INITIATED IN PROGRESS
|
This study provide a unique apportunity to alleviate multiple symptoms of long covid using one medicine |
| Emerald Study Phase II study | Bod ECS315 | The use of CBD in slowing progression of Motor Neuron Disease |
INITIATED IN PROGRESS
|
Collaboration with Gold Coast University Hospital |
| Phase I CBN INsomnia study | Bod Es310 | Using CBN treating primary insomnia |
INITIATED IN PROGRESS
|
Collaboration with Sydney University & The Woolcock Institute |
| Project Skin | Novel Protein |
Evaluating the efficancy of a novel protein for inhibiting free radical damage on skin |
INITIATED IN PROGRESS
|
At comletion, Bod will own uniqe and novel delivery format of an anti-aging agent for topical use |
